Repare (RPTX) Up 20% on Deal With Roche for Solid Tumor Drug - June 2, 2022 - Zacks

Retrieved on: 2022-06-02 19:33:48

Tags for this article:

Click the tags to see associated articles and topics

Repare (RPTX) Up 20% on Deal With Roche for Solid Tumor Drug - June 2, 2022 - Zacks. View article details on hiswai:

Excerpt

Repare Therapeutics (RPTX) signs a licensing agreement with Roche (RHHBY) to develop its lead candidate for solid tumor indications.

Article found on: www.zacks.com